Next Article in Journal
Recent Advances in N-Heterocyclic Small Molecules for Synthesis and Application in Direct Fluorescence Cell Imaging
Next Article in Special Issue
A Bridge too Far? Comparison of Transition Metal Complexes of Dibenzyltetraazamacrocycles with and without Ethylene Cross-Bridges: X-ray Crystal Structures, Kinetic Stability, and Electronic Properties
Previous Article in Journal
Reaction with ROO• and HOO• Radicals of Honokiol-Related Neolignan Antioxidants
Previous Article in Special Issue
Green Emissive Copper(I) Coordination Polymer Supported by the Diethylpyridylphosphine Ligand as a Luminescent Sensor for Overheating Processes
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 28
Issue 2
10.3390/molecules28020736
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Phosphine Oxide-Promoted Rh(I)-Catalyzed C–H Cyclization of Benzimidazoles with Alkenes

by
Mingzhen Lu
1,†,
Weiwei Xu
1,† and
Mengchun Ye
1,2,*
1
State Key Laboratory of Elemento-Organic Chemistry, College of Chemistry, Nankai University, Frontiers Science Center for New Organic Matter, Tianjin 300071, China
2
Haihe Laboratory of Sustainable Chemical Transformations, Tianjin 300192, China
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Molecules 2023, 28(2), 736; https://doi.org/10.3390/molecules28020736
Submission received: 29 November 2022 / Revised: 27 December 2022 / Accepted: 10 January 2023 / Published: 11 January 2023
(This article belongs to the Special Issue Recent Advance in Transition Metal Complexes and Their Applications)
Browse Figures
Review Reports Versions Notes

Abstract

:
Ligands play a critical role in promoting transition-metal-catalyzed C–H activation reactions. However, owing to high sensitivity of the reactivity of C–H activation to metal catalysts, the development of effective ligands has been a formidable challenge in the field. Rh(I)-catalyzed C–H cyclization of benzimidazoles with alkenes has been faced with low reactivity, often requiring very harsh conditions. To address this challenge, a phosphine oxide-enabled Rh(I)–Al bimetallic catalyst was developed for the reaction, significantly promoting the reactivity and allowing the reaction to run at 120 °C with up to 97% yield.

1. Introduction

Transition-metal-catalyzed C–H functionalization represents one of the most convenient methods for the construction of molecular complexity from readily available non-prefunctionalized substrates, and considerable progress has been achieved during the past several decades [1,2,3,4,5,6]. In the activation of inert C–H bonds either via electrophilic activation or via oxidative addition, transition metal catalysts often play critical roles in affecting reactivity and selectivity. In general, the catalytic ability of metal catalysts mainly relies on intrinsic properties of metals and of accompanying ligands. Therefore, the search for proper ligands to match metal catalysts is critical to most C–H functionalization reactions, and has become a long-term and challenging goal in the field [7,8,9,10]. Rh(I)-catalysis is recognized as a powerful catalytic method for C–H functionalization, and a large number of examples have been reported [11,12,13,14]. However, so far, only three types of ligand are available, namely, monophosphines [15,16,17], bisphosphines [18,19,20,21,22] and diene ligands [23,24] (Scheme 1a). Owing to limited availability of ligands, some Rh(I)-catalyzed C–H functionalizations have to be run under relatively harsh conditions, resulting in difficult selectivity control and low reaction applicability. In 2001, Ellman, Bergman and co-workers reported a Rh(I)-catalyzed C–H cyclization of benzimidazoles with alkenes [25], providing an elegant route to versatile polycyclic imidazoles that widely exist in bioactive molecules (Scheme 1b). However, the use of monophosphine (PCy3) as a ligand was not very effective, in general requiring very harsh conditions (over 160 °C and 20 h). Shortly after, to further optimize the reaction, a monophosphine (PPh3)-containing catalyst (RhCl(PPh3)) was then investigated; however, there was no obvious increase in reactivity observed, despite using a microwave-assisted technique at a higher temperature (250 °C) [26,27,28,29,30]. Switching back the monophosphine ligand with a Brønsted acid co-catalyst (PCy3·HCl) led to slightly improved reactivity, allowing 5 mol% Rh to be used at a slightly lower temperature (225 °C) (Scheme 1b). Therefore, the search for new types of more effective ligands, instead of traditional monophosphines, is highly desirable for this reaction as well as other Rh(I)-catalyzed C–H activations. Herein, we report the use of phosphine oxide (PO) as a distinctive type of ligand to significantly promote Rh(I)-catalyzed C–H cyclization of benzimidazoles with alkenes [31,32,33], providing the desired product in up to 97% yield at 120 °C (Scheme 1c). The bifunctional phosphine oxide ligand may ligate Rh(I) and Al-Lewis acid, thus activating both the Rh catalyst and benzimidazole substrates to give a big improvement in the reactivity.

2. Results

We recently explored a wide range of inert C–H and C–C bond activation reactions by using phosphine oxide-ligated Ni and Al bimetallic catalysis [34,35,36,37,38,39,40,41,42,43]. However, the replacement of nickel with other transition metals has been faced with big challenges, probably owing to a mismatch between the two metals, or between metal catalysts and substrates. To address this challenge, we turned our attention to the Rh(I)-catalyzed C–H cyclization of benzimidazoles with alkenes, hoping to develop a PO-ligated Rh–Al bimetallic system to improve the reactivity. As shown in Scheme 2, the investigation of transition metals with Ph2P(O)H as a ligand showed that versatile Pd catalysts were completely ineffective (entries 1 and 2), and only Co and Rh catalysts displayed moderate to good reactivity (entries 3–9). Among various Rh catalysts, [Rh(cod)2]BF4 gave the best result, providing the cyclized product in 68% yield (entry 5). Next, a large number of phosphine oxides were then examined (entries 10–12), and only bulky Mes-DAPO afforded a better yield: 84% (entry 12). In contrast, traditional phosphines gave very low yields under the same conditions (entries 13 and 14). With Mes-DAPO as the optimal ligand, the survey of Al-Lewis acids (entries 15–19) revealed that Me2AlCl was the best one, providing the product in 97% yield (entry 19). Moreover, with this catalytic system, the reaction temperature can be decreased to 120 °C without observing significant loss of yield (entries 20–23). Control experiments showed that the absence of either a Rh catalyst or Al-Lewis acid led to no reaction (entries 24 and 25), and the removal of phosphine oxide gave a very low yield (12%) (entry 26), suggesting that any component of Rh, Al or PO ligand would be essential to the reactivity.
With the optimal conditions in hand, we explored the scope of benzimidazoles (Scheme 3). Electron-deficient substituents such as carboester (2b), CF3 (2c), F (2d) and Cl (2e, 2f and 2g) on the phenyl ring of benzimidazoles can be highly compatible with the reaction, providing the corresponding products in 93–97% yield. In addition, electron-deficient heterocycle-bearing imidazole (2h) and fused aromatic ring-bearing imidazole (2i) were also suitable substrates, affording the corresponding products in 95% yield and 96% yield, respectively. In contrast, electron-donating substituents on the phenyl ring led to a relatively lower yield. For example, C6- and C7- monomethylated benzimidazoles gave the corresponding products in 61% yield and 52% yield, respectively (2j and 2k). In addition to terminal alkenes, an internal alkene was also tolerated, providing the corresponding product in 53% yield with the increased loading of catalysts.
After the completion of the investigation of substrate scope, we turned our attention to enantioselective control with chiral phosphine oxides (Scheme 4). Ellman et al. used a chiral bisphosphine-Rh(I) system to obtain a β-chiral stereocenter, while the construction of a more sterically hindered α-chiral stereocenter via Rh(I) catalysis still remains an elusive challenge. We examined a wide range of chiral phosphine oxides and found that only bulky phosphine oxide (L1) bearing a flexible chain gave 27% ee, suggesting that chiral phosphine oxide–Rh–Al would be a feasible enantioselective catalytic system. Surprisingly, a cyclohexane-1,2-diamine-derived phosphine oxide–Co–Al system provided better yield and ee (65% yield and 45% ee) in the same reaction, suggesting that a phosphine oxide ligand could also be a potential chiral ligand for Co(I) catalyzed C–H activation reactions.

3. Discussion

To gain more insights into the reaction, some mechanistic experiments were conducted (Scheme 5a). A deuterium-labeling experiment showed that C2–D was distributed in several positions in the product, suggesting that the migratory insertion of an alkene into the Rh–H species could be a reversible step.
In addition, parallel experiments revealed a low kinetic isotope effect (kH/kD = 1.44), implying that the C–H activation step may not be involved in the rate-determining step. On the basis of these results and previous studies, a plausible mechanism is proposed in Scheme 5b: the combination of the PO ligand, Rh and Al-Lewis acid in situ formed a bimetallic catalyst, which then coordinated to form benzimidazole at the Al terminus. Then, the Rh was directed to activate C2–H via oxidative addition, followed by migratory insertion of an alkene and reductive elimination to generate the desired product. Although the current result is not significantly exciting, it demonstrates for the first time that phosphine oxides can be used as new and effective ligands for Rh(I)- or Co(I)-catalyzed C–H activation reactions, in which proper ligands are still quite scarce. Moreover, phosphine oxides allow co-catalysis of Lewis acid metals to assist Rh(I) or Co(I) catalysis, providing more options for catalyst design.

4. Materials and Methods

4.1. Typical Procedure for Rh-Catalyzed C–H Cyclization

To a 15 mL oven-dried tube, we added Mes-DAPO (6.8 mg, 10 mol%), [Rh(cod)2]BF4 (8.1 mg, 10 mol%), benzimidazole derivative (0.2 mmol) and dry degassed toluene (2.0 mL) under N2 atmosphere. Then, AlMe2Cl (1.0 M/hexane, 40 μL, 20 mol%) was added, and the tube was sealed. The reaction mixture was heated at 120 °C for 3 h and then cooled to room temperature. The resulting solution was quenched with 5% EDTA disodium salt solution (2 mL), filtered through silica gel (EtOAc as the eluent) and concentrated in vacuo. The residue was further purified with flash column chromatography on silica gel (eluting with EtOAc/hexanes) to give the pure product (see Supplementary Materials).

4.1.1. 3-Methyl-2,3-dihydro-1H-benzo[d]pyrrolo[1,2-a]imidazole (2a) [39]

1H NMR (400 MHz, CDCl3) δ 7.80–7.64 (m, 1H), 7.31–7.16 (m, 3H), 4.18–4.07 (m, 1H), 4.06–3.91 (m, 1H), 3.46–3.27 (m, 1H), 2.94–2.81 (m, 1H), 2.32–2.22 (m, 1H), 1.48 (d, J = 7.0 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 164.5, 148.7, 132.4, 121.9, 121.7, 119.7, 109.6, 42.0, 35.4, 31.0, 18.1.

4.1.2. Methyl-3-methyl-2,3-dihydro-1H-benzo[d]pyrrolo[1,2-a]imidazole-6-carboxylate (2b) [39]

1H NMR (400 MHz, CDCl3) δ 8.39 (s, 1H), 7.93 (d, J = 8.4 Hz, 1H), 7.27 (d, J = 8.3 Hz, 1H), 4.18–4.11 (m, 1H), 4.05–3.97 (m, 1H), 3.91 (s, 3H), 3.43–3.31 (m, 1H), 2.96–2.85 (m, 1H), 2.35–2.24 (m, 1H), 1.48 (d, J = 7.0 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 167.9, 166.3, 148.4, 135.7, 123.8, 122.0, 109.2, 77.5, 52.1, 42.1, 35.4, 31.1, 18.0.

4.1.3. 3-Methyl-6-(trifluoromethyl)-2,3-dihydro-1H-benzo[d]pyrrolo[1,2-a]imidazole (2c) [39]

1H NMR (400 MHz, CDCl3) δ 7.96 (s, 1H), 7.45 (d, J = 8.4 Hz, 1H), 7.35 (d, J = 8.4 Hz, 1H), 4.24–4.12 (m, 1H), 4.12–3.99 (m, 1H), 3.49–3.34 (m, 1H), 2.99–2.87 (m, 1H), 2.38–2.27 (m, 1H), 1.50 (d, J = 7.1 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 166.6, 148.1, 134.4, 126.4, 124.4, 124.1, 123.7, 119.1, 119.0, 117.3, 117. 3, 109.9, 42.2, 35.4, 31.2, 18.0. 19F NMR (376 MHz, CDCl3) δ −60.5.

4.1.4. 6-Fluoro-3-methyl-2,3-dihydro-1H-benzo[d]pyrrolo[1,2-a]imidazole (2d) [39]

1H NMR (400 MHz, CDCl3) δ 7.36 (d, J = 9.7 Hz, 1H), 7.16 (dd, J = 8.7, 4.6 Hz, 1H), 6.99–6.85 (m, 1H), 4.15–4.05 (m, 1H), 4.02–3.92 (m, 1H), 3.41–3.25 (m, 1H), 2.95–2.80 (m, 1H), 2.32–2.21 (m, 1H), 1.46 (d, J = 7.0 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 166.0, 160.3, 158.0, 158.0, 149.1, 149.0, 129.0, 110.1, 109.8, 109.7, 109.6, 105.8, 105.5, 42.2, 35.4, 31.3, 18.0. 19F NMR (376 MHz, CDCl3) δ −121.6.

4.1.5. 6,7-Dichloro-3-methyl-2,3-dihydro-1H-benzo[d]pyrrolo[1,2-a]imidazole (2e) [39]

1H NMR (400 MHz, CDCl3) δ 7.72 (s, 1H), 7.32 (s, 1H), 4.12–4.01 (m, 1H), 4.00–3.88 (m, 1H), 3.40–3.26 (m, 1H), 2.95–2.82 (m, 1H), 2.34–2.22 (m, 1H), 1.45 (d, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 166.7, 148.0, 131.6, 125.7, 125.6, 120.7, 110.9, 42.2, 35.3, 31.1, 17.9.

4.1.6. 7-Chloro-3-methyl-2,3-dihydro-1H-benzo[d]pyrrolo[1,2-a]imidazole (2f) [39]

1H NMR (400 MHz, CDCl3) δ 7.58 (d, J = 8.3 Hz, 1H), 7.27 (s, 1H), 7.15 (d, J = 8.1 Hz, 1H), 4.28–4.07 (m, 1H), 4.07–3.90 (m, 1H), 3.58–3.24 (m, 1H), 3.09–2.78 (m, 1H), 2.44–2.19 (m, 1H), 1.47 (d, J = 6.1 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 165.4, 147.2, 132.9, 127.6, 122.3, 120.4, 109.8, 42.1, 35.3, 31.0, 18.0.

4.1.7. 6-Chloro-3-methyl-2,3-dihydro-1H-benzo[d]pyrrolo[1,2-a]imidazole (2g) [39]

1H NMR (400 MHz, CDCl3) δ 7.76 (s, 1H), 7.35–7.22 (m, 2H), 4.26–4.17 (m, 1H), 4.14–4.02 (m, 1H), 3.56–3.36 (m, 1H), 3.04–2.94 (m, 1H), 2.47–2.34 (m, 1H), 1.57 (d, J = 7.0 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 165.9, 149.3, 131.0, 127.4, 122.4, 119.5, 110.3, 42.2, 35.3, 31.2, 18.0.

4.1.8. 6-Methyl-7,8-dihydro-6H-pyrrolo[2′,1′:2,3]imidazo[4,5-b]pyridine (2h) [39]

1H NMR (400 MHz, CDCl3) δ 8.25 (d, J = 4.8 Hz, 1H), 7.93 (d, J = 8.0 Hz, 1H), 7.15 (dd, J = 8.0, 4.9 Hz, 1H), 4.34–4.24 (m, 1H), 4.16–4.06 (m, 1H), 3.50–3.28 (m, 1H), 2.99–2.81 (m, 1H), 2.35–2.25 (m, 1H), 1.49 (d, J = 7.0 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 165.8, 146.1, 143.0, 140.8, 127.1, 117.9, 41.5, 35.3, 31.6, 17.8.

4.1.9. 3-Methyl-2,3-dihydro-1H-naphtho[2,3-d]pyrrolo[1,2-a]imidazole (2i) [39]

1H NMR (400 MHz, CDCl3) δ 8.15 (s, 1H), 7.96 (s, 1H), 7.88 (s, 1H), 7.62 (s, 1H), 7.43–7.31 (m, 2H), 4.18–4.06 (m, 1H), 4.05–3.93 (m, 1H), 3.46–3.30 (m, 1H), 2.94–2.81 (m, 1H), 2.36–2.23 (m, 1H), 1.56–1.44 (m, 3H). 13C NMR (100 MHz, CDCl3) δ 168.8, 149.0, 133.3, 130.2, 128.6, 127.4, 124.2, 123.4, 116.3, 105.2, 42.0, 35.3, 31.3, 17.9.

4.1.10. 3,7-Dimethyl-2,3-dihydro-1H-benzo[d]pyrrolo[1,2-a]imidazole (2j) [39]

1H NMR (400 MHz, CDCl3) δ 7.57 (d, J = 8.2 Hz, 1H), 7.08 (s, 1H), 7.02 (d, J = 8.3 Hz, 1H), 4.14–4.02 (m, 1H), 4.01–3.88 (m, 1H), 3.43–3.24 (m, 1H), 2.91–2.81 (m, 1H), 2.46 (s, 3H), 2.31–2.19 (m, 1H), 1.46 (d, J = 7.0 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 164.0, 146.5, 132.5, 131.8, 123.2, 119.1, 109.6, 41.8, 35.4, 31.0, 21.8, 18.1.

4.1.11. 3,8-Dimethyl-2,3-dihydro-1H-benzo[d]pyrrolo[1,2-a]imidazole (2k) [39]

1H NMR (400 MHz, CDCl3) δ 7.52 (d, J = 8.0 Hz, 1H), 7.07 (t, J = 7.6 Hz, 1H), 6.92 (d, J = 7.1 Hz, 1H), 4.47–4.29 (m, 1H), 4.27–4.10 (m, 1H), 3.39–3.18 (m, 1H), 2.91–2.80 (m, 1H), 2.57 (s, 3H), 2.33–2.16 (m, 1H), 1.46 (d, J = 7.0 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 164.3, 148.3, 131.8, 123.2, 121.9, 120.7, 117.3, 44.2, 35.5, 30.6, 18.1, 17.1.

4.1.12. 3-Propyl-2,3-dihydro-1H-benzo[d]pyrrolo[1,2-a]imidazole (2l) [39]

1H NMR (400 MHz, CDCl3) δ 7.80–7.66 (m, 1H), 7.32–7.27 (m, 1H), 7.24–7.16 (m, 2H), 4.17–4.08 (m, 1H), 4.06–3.93 (m, 1H), 3.39–3.17 (m, 1H), 2.91–2.76 (m, 1H), 2.38–2.29 (m, 1H), 2.05–1.95 (m, 1H), 1.66–1.49 (m, 3H), 0.99 (t, J = 7.0 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 164.0, 148.7, 132.3, 121.9, 121.7, 119.8, 109.6, 42.1, 36.1, 35.5, 33.3, 20.7, 14.3.

4.2. Procedure for Enantioselective C–H Cyclization

4.2.1. Procedure for Enantioselective Rh-Catalyzed C–H Cyclization

To an oven-dried tube (15 mL), we added ligand L1 (11.1 mg, 10 mol%), [Rh(cod)2]BF4 (8.1 mg, 10 mol%), benzimidazole derivative (0.2 mmol) and dry degassed toluene (2.0 mL) under N2 atmosphere. Then AlMe2Cl (1.0 M/hexane, 40 μL, 20 mol%) was added, and the tube was sealed. The reaction mixture was heated at 120 °C for 3 h and then cooled to room temperature. The resulting solution was quenched with 5% EDTA disodium salt solution (2 mL), filtered through silica gel (EtOAc as the eluent) and concentrated in vacuo. The residue was further purified with flash column chromatography on silica gel (eluting with EtOAc/hexanes) to give the pure product. (R)-3-Methyl-2,3-dihydro-1H-benzo[d]pyrrolo[1,2-a]imidazole. HPLC condition: Chiralpak IC column, n-hexane/i-PrOH = 85:15, 1.0 mL/min, 254 nm, tr-major = 15.6 min, 27% ee. [ α ] D 28 + 2.64 (c 0.5, CHCl3).

4.2.2. Procedure for Enantioselective Co-Catalyzed C–H Cyclization

To an oven-dried tube (15 mL), we added ligand L2 (10.8 mg, 10 mol%), PCy3 (5.6 mg, 10 mol%), CoCl2 (2.6 mg, 10 mol%), Zn (6.5 mg, 50 mol%), benzimidazole derivative (0.2 mmol, 1 equiv.) and dry degassed toluene (2.0 mL) under N2 atmosphere. Then, AlMe3 (1.0 M/hexane, 80 μL, 40 mol%) was added, and the tube was sealed. The reaction mixture was heated at 120 °C for 3 h and then cooled to room temperature. The resulting solution was quenched with 5% EDTA disodium salt solution (2 mL), filtered through silica gel (EtOAc as the eluent) and concentrated in vacuo. The residue was further purified with flash column chromatography on silica gel (eluting with EtOAc/hexanes) to give the pure product. (S)-3-Methyl-2,3-dihydro-1H-benzo[d]pyrrolo[1,2-a]imidazole. HPLC condition: Chiralpak IC column, n-hexane/i-PrOH = 85:15, 1.0 mL/min, 254 nm, tr-major = 22.1 min, 45% ee. [ α ] D 28 −6.80 (c 0.5, CHCl3).

4.3. Procedure for Mechanistic Experiments

The deuterium-labeling experiment and parallel experiments were set up following the general procedure by using 1a or d-1a as substrates, respectively. Aliquots were taken at proper intervals. The yield was determined using 1H NMR with CH2Br2 as an internal standard. Data points represent the average of two runs.

5. Conclusions

A phosphine oxide-ligated Rh–Al bimetal-catalyzed selective C2–H cyclization of benzimidazoles with alkenes was developed, providing a series of polycyclic imidazoles in up to 97% yield under relatively mild conditions (120 °C and 3 h). This work demonstrated that the phosphine oxide ligand is a distinctive type of ligand for Rh(I) catalysis compared with traditional monophosphines, bisphosphines and diene ligands, and a wide range of applications may be expected in the future.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules28020736/s1, File S1: 1H/13C-NMR spectra and HRMS for each compound [39,40].

Author Contributions

Conceptualization, M.Y.; methodology, M.L. and W.X.; investigation, M.L. and W.X.; writing, M.L., W.X. and M.Y.; funding acquisition, M.Y. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the National Natural Science Foundation of China (21871145 and 22188101); the Haihe Laboratory of Sustainable Chemical Transformations and “Frontiers Science Center for New Organic Matter”, Nankai University (63181206); and the Fundamental Research Funds for the Central Universities for Financial Support.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Samples of the compounds are not available from the authors.

References

  1. Dalton, T.; Faber, T.; Glorius, F. C–H Activation: Toward Sustainability and Applications. ACS Central Sci. 2021, 7, 245–261. [Google Scholar] [CrossRef] [PubMed]
  2. Achar, T.K.; Maiti, S.; Jana, S.; Maiti, D. Transition Metal Catalyzed Enantioselective C(sp2)–H Bond Functionalization. ACS Catal. 2020, 10, 13748–13793. [Google Scholar] [CrossRef]
  3. Gandeepan, P.; Muller, T.; Zell, D.; Cera, G.; Warratz, S.; Ackermann, L. 3d Transition Metals for C–H Activation. Chem. Rev. 2019, 119, 2192–2452. [Google Scholar] [PubMed]
  4. Wozniak, L.; Cramer, N. Enantioselective C-H Bond Functionalizations by 3d Transition-Metal Catalysts. Trends Chem. 2019, 1, 471–484. [Google Scholar] [CrossRef]
  5. Loup, J.; Dhawa, U.; Pesciaioli, F.; Wencel-Delord, J.; Ackermann, L. Enantioselective C−H Activation with Earth-Abundant 3d Transition Metals. Angew. Chem. Int. Ed. 2019, 58, 12803–12818. [Google Scholar] [CrossRef]
  6. Saint-Denis, T.G.; Zhu, R.-Y.; Chen, G.; Wu, Q.-F.; Yu, J.-Q. Enantioselective C(sp3)-H Bond Activation by Chiral Transition Metal Catalysts. Science 2018, 359, eaao4798. [Google Scholar] [CrossRef] [Green Version]
  7. Su, B.; Hartwig, J.F. Development of Chiral Ligands for the Transition-Metal-Catalyzed Enantioselective Silylation and Borylation of C–H Bonds. Angew. Chem. Int. Ed. 2022, 61, e202113343. [Google Scholar]
  8. Goswami, N.; Bhattacharya, T.; Maiti, D. Transient Directing Ligands for Selective Metal-Catalysed C-H Activation. Nat. Rev. Chem. 2021, 5, 646–659. [Google Scholar] [CrossRef]
  9. Clevenger, A.L.; Stolley, R.M.; Aderibigbe, J.; Louie, J. Trends in the Usage of Bidentate Phosphines as Ligands in Nickel Catalysis. Chem. Rev. 2020, 120, 6124–6196. [Google Scholar] [CrossRef]
  10. Zhao, Q.; Meng, G.; Szostak, M.; Nolan, S.P. N-Heterocyclic Carbene (NHC) Complexes in C-H Activation Reactions. Chem. Rev. 2020, 120, 1981–2048. [Google Scholar] [CrossRef]
  11. Davison, R.T.; Kuker, E.L.; Dong, V.M. Teaching Aldehydes New Tricks Using Rhodium-and Cobalt- Hydride Catalysis. Acc. Chem. Res. 2021, 54, 1236–1250. [Google Scholar] [CrossRef] [PubMed]
  12. Dongbang, S.; Confair, D.N.; Ellman, J.A. Rhodium-Catalyzed C−H Alkenylation/Electrocyclization Cascade Provides Dihydropyridines That Serve as Versatile Intermediates to Diverse Nitrogen Heterocycles. Acc. Chem. Res. 2021, 54, 1766–1778. [Google Scholar] [CrossRef] [PubMed]
  13. Wang, Q.; Liu, C.-X.; Gu, Q.; You, S.-L. Chiral CpxRh complexes for C–H functionalization reactions. Sci. Bull. 2021, 66, 210–213. [Google Scholar] [CrossRef]
  14. Zhang, Z.; Durand, N.; Soulé, J.-F. How Rhodium(I)-Catalyzed Phosphorus(III)-Directed C–H Bond Functionalizations Can Improve the Catalytic Activities of Phosphines. Synlett 2022, 33, 705–712. [Google Scholar]
  15. Coulter, M.M.; Kou, K.G.M.; Galligan, B.; Dong, V.M. Regioand Enantioselective Intermolecular Hydroacylation: Substrate-Directed Addition of Salicylaldehydes to Homoallylic Sulfides. J. Am. Chem. Soc. 2010, 132, 16330–16333. [Google Scholar] [CrossRef]
  16. Tran, D.N.; Cramer, N. syn-Selective rhodium(I)-catalyzed allylations of ketimines proceeding through a directed C-H activation/allene addition sequence. Angew. Chem. Int. Ed. 2010, 49, 8181–8184. [Google Scholar] [CrossRef]
  17. Duttwyler, S.; Lu, C.; Rheingold, A.L.; Bergman, R.G.; Ellman, J.A. Highly Diastereoselective Synthesis of Tetrahydropyridines by a C−H Activation−Cyclization−Reduction Cascade. J. Am. Chem. Soc. 2012, 134, 4064–4067. [Google Scholar] [CrossRef] [Green Version]
  18. Tran, D.N.; Cramer, N. Enantioselective Rhodium(I)-Catalyzed [3 + 2] Annulations of Aromatic Ketimines Induced by Directed C-H Activations. Angew. Chem. Int. Ed. 2011, 50, 11098–11102. [Google Scholar] [CrossRef]
  19. Kuninobu, Y.; Yamauchi, K.; Tamura, N.; Seiki, T.; Takai, K. Rhodium-Catalyzed Asymmetric Synthesis of Spirosilabifluorene Derivatives. Angew. Chem. Int. Ed. 2013, 52, 1520–1522. [Google Scholar] [CrossRef]
  20. Zhang, Q.W.; An, K.; Liu, L.C.; Yue, Y.; He, W. Rhodiumcatalyzed Enantioselective Intramolecular C-H Silylation for the Syntheses of Planar-Chiral Metallocene Siloles. Angew. Chem. Int. Ed. 2015, 54, 6918–6921. [Google Scholar] [CrossRef]
  21. Lee, T.; Wilson, T.W.; Berg, R.; Ryberg, P.; Hartwig, J.F. Rhodium-Catalyzed Enantioselective Silylation of Arene C-H Bonds: Desymmetrization of Diarylmethanols. J. Am. Chem. Soc. 2015, 137, 6742–6745. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Park, J.-W.; Chen, Z.; Dong, V.M. Rhodium-Catalyzed Enantioselective Cycloisomerization to Cyclohexenes Bearing Quaternary Carbon Centers. J. Am. Chem. Soc. 2016, 138, 3310–3313. [Google Scholar] [CrossRef] [PubMed]
  23. Shibata, T.; Shizuno, T.; Sasaki, T. Enantioselective Synthesis of Planar-Chiral Benzosiloloferrocenes by Rh-Catalyzed Intramolecular C–H Silylation. Chem. Commun. 2015, 51, 7802–7804. [Google Scholar] [CrossRef]
  24. Zhu, D.-X.; Xia, H.; Liu, J.-G.; Chung, L.W.; Xu, M.-H. Regiospecific and Enantioselective Arylvinylcarbene Insertion of a C-H Bond of Aniline Derivatives Enabled by a Rh(I)-Diene Catalyst. J. Am. Chem. Soc. 2021, 143, 2608–2619. [Google Scholar] [CrossRef] [PubMed]
  25. Tan, K.L.; Bergman, R.G.; Ellman, J.A. Annulation of Alkenyl-Substituted Heterocycles via Rhodium-Catalyzed Intramolecular C–H Activated Coupling Reactions. J. Am. Chem. Soc. 2001, 123, 2685–2686. [Google Scholar] [CrossRef] [PubMed]
  26. Tan, K.L.; Vasudevan, A.; Bergman, R.G.; Ellman, J.A.; Souers, A.J. Microwave-Assisted C−H Bond Activation:  A Rapid Entry into Functionalized Heterocycles. Org. Lett. 2003, 5, 2131–2134. [Google Scholar] [CrossRef]
  27. Tan, K.L.; Bergman, R.G.; Ellman, J.A. Intermediacy of an N-Heterocyclic Carbene Complex in the Catalytic C−H Activation of a Substituted Benzimidazole. J. Am. Chem. Soc. 2002, 124, 3202–3203. [Google Scholar] [CrossRef]
  28. Wiedemann, S.H.; Lewis, J.C.; Ellman, J.A.; Bergman, R.G. Experimental and Computational Studies on the Mechanism of N-Heterocycle C−H Activation by Rh(I). J. Am. Chem. Soc. 2006, 128, 2452–2462. [Google Scholar] [CrossRef] [Green Version]
  29. Lewis, J.C.; Bergman, R.G.; Ellman, J.A. Direct Functionalization of Nitrogen Heterocycles via Rh-Catalyzed C−H Bond Activation. Acc. Chem. Res. 2008, 41, 1013–1025. [Google Scholar] [CrossRef] [Green Version]
  30. Tsai, A.S.; Wilson, R.M.; Harada, H.; Bergman, R.G.; Ellman, J.A. Rhodium Catalyzed Enantioselective Cyclization of Substituted Imidazoles via C–H Bond Activation. Chem. Commun. 2009, 26, 3910–3912. [Google Scholar] [CrossRef] [Green Version]
  31. Ackermann, L.; Born, R.; Spatz, J.H.; Althammer, A.; Gschrei, C.J. Air-Stable Phosphine Oxides as Preligands for Catalytic Activation Reactions of C–Cl, C–F, and C–H Bonds. Pure Appl. Chem. 2006, 78, 209–214. [Google Scholar] [CrossRef]
  32. Shaikh, T.M.; Weng, C.-M.; Hong, F.-E. Secondary Phosphine Oxides: Versatile Ligands in Transition Metal-Catalyzed Cross-Coupling Reactions. Coord. Chem. Rev. 2016, 256, 771–803. [Google Scholar] [CrossRef]
  33. Van Leeuwen, P.W.N.M.; Cano, I.; Freixa, Z. Secondary Phosphine Oxides: Bifunctional Ligands in Catalysis. ChemCatChem 2020, 12, 3982–3994. [Google Scholar] [CrossRef]
  34. Wang, Y.-X.; Ye, M. Recent Advances in Ni−Al Bimetallic Catalysis for Unreactive Bond Transformation. Sci. China Chem. 2018, 61, 1004–1013. [Google Scholar] [CrossRef]
  35. Li, J.-F.; Luan, Y.-X.; Ye, M. Bimetallic anchoring catalysis for C–H and C–Cactivation. Sci. China Chem. 2021, 64, 1923–1937. [Google Scholar] [CrossRef]
  36. Luan, Y.-X.; Ye, M. Ligand-ligated Ni–Al bimetallic catalysis for C–H and C–C bond activation. Chem. Commun. 2022, 58, 12260–12273. [Google Scholar] [CrossRef] [PubMed]
  37. Donets, P.A.; Cramer, N. Diaminophosphine Oxide Ligand Enabled Asymmetric Nickel-Catalyzed Hydrocarbamoylations of Alkenes. J. Am. Chem. Soc. 2013, 135, 11772–11775. [Google Scholar] [CrossRef]
  38. Liu, Q.-S.; Wang, D.-Y.; Yang, Z.-J.; Luan, Y.-X.; Yang, J.-F.; Li, J.-F.; Pu, Y.-G.; Ye, M. Ni−Al Bimetallic Catalyzed Enantioselective Cycloaddition of Cyclopropyl Carboxamide with Alkyne. J. Am. Chem. Soc. 2017, 139, 18150–18153. [Google Scholar] [CrossRef]
  39. Wang, Y.-X.; Qi, S.-L.; Luan, Y.-X.; Han, X.-W.; Wang, S.; Chen, H.; Ye, M. Enantioselective Ni−Al Bimetallic Catalyzed exo-Selective C−H Cyclization of Imidazoles with Alkenes. J. Am. Chem. Soc. 2018, 140, 5360–5364. [Google Scholar] [CrossRef]
  40. Chen, H.; Wang, Y.-X.; Luan, Y.-X.; Ye, M. Enantioselective Twofold C−H Annulation of Formamides and Alkynes without Built-in Chelating Groups. Angew. Chem. Int. Ed. 2020, 59, 9428–9432. [Google Scholar] [CrossRef]
  41. Qi, S.-L.; Liu, Y.-P.; Luan, Y.-X.; Ye, M. Ni-Catalyzed Hydroarylation of Alkynes with Unactivated β-C(sp2)−H Bonds. Nat. Commun. 2022, 13, 2938–2946. [Google Scholar] [CrossRef] [PubMed]
  42. Wang, Y.-X.; Zhang, F.-P.; Chen, H.; Li, Y.; Li, J.-F.; Ye, M. Enantioselective Nickel-Catalyzed C(sp3)−H Activation of Formamides. Angew. Chem. Int. Ed. 2022, 61, e202209625. [Google Scholar]
  43. Li, J.-F.; Pan, D.; Wang, H.-R.; Zhang, T.; Li, Y.; Huang, G.; Ye, M. Enantioselective C2−H Alkylation of Pyridines with 1,3-Dienes via Ni−Al Bimetallic Catalysis. J. Am. Chem. Soc. 2022, 144, 18810–18816. [Google Scholar] [CrossRef] [PubMed]
Molecules 28 00736 sch001 550
Scheme 1. Rh(I)-catalyzed C-H cyclization of benzimidazoles with alkenes.
Scheme 1. Rh(I)-catalyzed C-H cyclization of benzimidazoles with alkenes.
Molecules 28 00736 sch001
Molecules 28 00736 sch002 550
Scheme 2. Reaction optimization. Reaction conditions: 1a (0.2 mmol), catalyst (10 mol%), Lewis acid (20 mol%) and ligand (10 mol%) in toluene under N2; yield for isolated product. MAD = methylaluminum bis (2,6-di-tert-butyl 4-methylphenoxide).
Scheme 2. Reaction optimization. Reaction conditions: 1a (0.2 mmol), catalyst (10 mol%), Lewis acid (20 mol%) and ligand (10 mol%) in toluene under N2; yield for isolated product. MAD = methylaluminum bis (2,6-di-tert-butyl 4-methylphenoxide).
Molecules 28 00736 sch002
Molecules 28 00736 sch003 550
Scheme 3. Substrate scope. Reaction conditions: 1 (0.2 mmol), [Rh(cod)2]BF4 (10 mol%), AlMe2Cl (20 mol%) and Mes-DAPO (10 mol%) in toluene (1 mL) at 120 °C under N2; yield was determined using 1H NMR with CH2Br2 as the internal standard. a AlMe3 instead of AlMe2Cl, 150 °C. b [Rh(cod)2]BF4 (20 mol%), Mes-DAPO (20 mol%) and AlMe2Cl (40 mol%).
Scheme 3. Substrate scope. Reaction conditions: 1 (0.2 mmol), [Rh(cod)2]BF4 (10 mol%), AlMe2Cl (20 mol%) and Mes-DAPO (10 mol%) in toluene (1 mL) at 120 °C under N2; yield was determined using 1H NMR with CH2Br2 as the internal standard. a AlMe3 instead of AlMe2Cl, 150 °C. b [Rh(cod)2]BF4 (20 mol%), Mes-DAPO (20 mol%) and AlMe2Cl (40 mol%).
Molecules 28 00736 sch003
Molecules 28 00736 sch004 550
Scheme 4. Investigation of enantioselective control.
Scheme 4. Investigation of enantioselective control.
Molecules 28 00736 sch004
Molecules 28 00736 sch005 550
Scheme 5. Mechanistic experiments and proposed mechanism.
Scheme 5. Mechanistic experiments and proposed mechanism.
Molecules 28 00736 sch005
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Lu, M.; Xu, W.; Ye, M. Phosphine Oxide-Promoted Rh(I)-Catalyzed C–H Cyclization of Benzimidazoles with Alkenes. Molecules 2023, 28, 736. https://doi.org/10.3390/molecules28020736

AMA Style

Lu M, Xu W, Ye M. Phosphine Oxide-Promoted Rh(I)-Catalyzed C–H Cyclization of Benzimidazoles with Alkenes. Molecules. 2023; 28(2):736. https://doi.org/10.3390/molecules28020736

Chicago/Turabian Style

Lu, Mingzhen, Weiwei Xu, and Mengchun Ye. 2023. "Phosphine Oxide-Promoted Rh(I)-Catalyzed C–H Cyclization of Benzimidazoles with Alkenes" Molecules 28, no. 2: 736. https://doi.org/10.3390/molecules28020736

Article Metrics

Back to TopTop